Viewing Study NCT00270894


Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2026-02-09 @ 12:03 PM
Study NCT ID: NCT00270894
Status: COMPLETED
Last Update Posted: 2012-03-20
First Post: 2005-12-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
Sponsor: Accelerated Community Oncology Research Network
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None neoadjuvant chemotherapy View
None HER2 positive breast cancer View
None stage II - III breast cancer View